Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Transcriptional Map of Ovarian Cancer at the Single Cell Level
- Status
- RECRUITING
- Phase
- N/A
Exercise Preconditioning in Ovarian Cancer
- Status
- TERMINATED
- Phase
- NA
13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
- Status
- RECRUITING
- Phase
- N/A
A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Thiol-disulfide Homeostasis in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy
- Status
- RECRUITING
- Phase
- NA
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Status
- RECRUITING
- Phase
- N/A
TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Patient-Reported Outcomes Among Women Wtih Gynecological Cancer (The CONNECT Study)
- Status
- UNKNOWN
- Phase
- NA
OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Connecting Families to Overcome Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA